Clinical Trial Update: Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial of intra-arterial oxaliplatin plus capecitabine for liver metastases from colorectal cancer has been terminated (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: AllVascular | Conditions: Liver Metastasis Colon Cancer | Phase 1, Phase 2 | Status: TERMINATED